NCT01662661View on ClinicalTrials.gov

A Study to Compare the Bioavailability of JNJ-47910382 Formulated as a Tablet and as Suspension in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

September 30, 2012

Conditions
Healthy Participants
Interventions
DRUG

JNJ-47910382 (suspension)

Type=exact number, unit=mg, number=200, form=suspension, route=oral. JNJ-47910382 administered on Day 1.

DRUG

JNJ-47910382 (tablet)

Type=exact number, unit=mg, number=200, form=tablet, route=oral. JNJ-47910382 administered on Day 1.

Trial Locations (1)

Unknown

Antwerp

All Listed Sponsors
lead

Janssen R&D Ireland

INDUSTRY

NCT01662661 - A Study to Compare the Bioavailability of JNJ-47910382 Formulated as a Tablet and as Suspension in Healthy Participants | Biotech Hunter | Biotech Hunter